NCT05072171

Brief Summary

The study utilizes the same tissue specimens gathered for previous investigations and removed from 15 patients already operated for inguinal hernia, who for different reasons needed additional surgery in the previously operated groin.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2013

Longer than P75 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
8.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2021

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

September 16, 2021

Completed
22 days until next milestone

First Posted

Study publicly available on registry

October 8, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

October 18, 2021

Status Verified

October 1, 2021

Enrollment Period

8.7 years

First QC Date

September 16, 2021

Last Update Submit

October 8, 2021

Conditions

Outcome Measures

Primary Outcomes (8)

  • assessment of NGF stained areas

    evidence in ProFlor of NGF in the short term post implantation

    3-5 weeks postop

  • assessment of NGF stained areas

    evidence of NGF in the midterm post implantation of ProFlor

    3-4 months postop.

  • assessment of NGF stained areas

    evidence in ProFlor of NGF in the long term post implantation

    6-8 months post implantation

  • assessment of NGF stained areas

    evidence in ProFlor of NGF in the extra long term post implantation

    >3 years post implantation of ProFlor

  • assessment of NGFR p75 stained areas

    evidence in ProFlor of NGFR p75 in the short term post implantation

    3-5 weeks postop

  • assessment of NGFR p75 stained areas

    evidence in ProFlor of NGFR p75 in the midterm post implantation

    3-4 months postop.

  • assessment of NGFR p75 stained areas

    evidence in ProFlor of NGFR p75 in the long term post implantation

    6-8 months post implantation

  • assessment of NGFR p75 stained areas

    evidence in ProFlor of NGFR p75 in the extra long term post implantation

    >3 years post implantation of ProFlor

Study Arms (4)

Biopsies from 3D hernia scaffold ProFlor in the short term

3 patients biopsied 3-5 weeks post implantation of ProFlor

Procedure: Inguinal hernia repair with dynamic prosthesis

Biopsies from 3D hernia scaffold ProFlor in the midterm

5 patients biopsied 3-4 months post implantation of ProFlor

Procedure: Inguinal hernia repair with dynamic prosthesis

Biopsies from 3D hernia scaffold ProFlor in the long term

4 patients biopsied between 3-4 months post implantation of ProFlor

Procedure: Inguinal hernia repair with dynamic prosthesis

Biopsies from 3D hernia scaffold ProFlor in the extra long term

3 patients biopsied more than 3 years after implantation of ProFlor

Procedure: Inguinal hernia repair with dynamic prosthesis

Interventions

Tissue specimens excised at the above defined postoperative stages were fixed in neutral-buffered 10% formalin and routinely processed to paraffin wax. Sections (4 μm thick) were cut and stored at room temperature until use. Sections were stained with hematoxylin and eosin (H\&E) for histological analysis and Azan trichrome (Bioptica) staining to evaluate muscular tissue in the implant fabric.

Biopsies from 3D hernia scaffold ProFlor in the extra long termBiopsies from 3D hernia scaffold ProFlor in the long termBiopsies from 3D hernia scaffold ProFlor in the midtermBiopsies from 3D hernia scaffold ProFlor in the short term

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Biopsies from ProFlor carried out in 15 patients: 3 in the short term postop. between 3-5 weeks, 5 in the mid-term between 3-4 months postop., 4 in the long-term between 6-8 months postop. and the latter 3 in the extra-long term postop., more than 3 years after implantation

You may qualify if:

  • patients already operated for inguinal hernia with ProFlor, who for different reasons needed additional surgery in the previously operated groin
  • ASA score \>4

You may not qualify if:

  • Patients who do not underwent inguinal hernia repair with ProFlor

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Hernia, Inguinal

Condition Hierarchy (Ancestors)

Hernia, AbdominalHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Antonino Agrusa, Professor

    University of Palermo - Italy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associated professor

Study Record Dates

First Submitted

September 16, 2021

First Posted

October 8, 2021

Study Start

January 1, 2013

Primary Completion

September 1, 2021

Study Completion

December 31, 2021

Last Updated

October 18, 2021

Record last verified: 2021-10